{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Endometrial Carcinoma Staging Update - Vol. 44, No. 17

Activity Steps

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Discuss endometrial cancer statistics in the United States and the significance of molecular profiling in endometrial cancer
  2. Describe anatomic landmarks and histologic classification used in International Federation of Gynecology and Obstetrics (FIGO) 2023 endometrial cancer staging.
  3. Explain endometrial cancer staging using the FIGO 2023 classification.
Price: $49.00

Credits:

  • ACCME 2.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: PGO1124B
Published: November 30, 2024
Expires: 11/29/2026
Required Passing Score: 7/10 (70%)
Authors: Jason Conger, MD, Prathista Koirala, MD, PhD, and Enrique Hernandez, MD
Categories: Obstetrical , Women's Health
Specialties: Gynecology, OB/GYN